DXI Capital Corp.

DXI Capital Corp.

DXIEF
DXI Capital Corp.US flagOther OTC
0.00
USD
- -
- -
1.43MMarket Cap
DXI Capital Corp.
DXIEF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
39.92
40.99
40.7
36.67
24.39
31.28
25.54
23.51
11.42
4.57
1.88
0.68
0.08
- -
- -
- -
- -
Revenue per Share
-144.65
-81.13
-25.67
-45.9
-41.66
-8.65
-20.33
-19.48
-13.03
-8.44
-11.23
-2.77
1.45
-0.02
-0.01
-0.02
-0.01
Basic EPS, GAAP
-8.42
-7.64
-23.51
-34.25
-27.34
-3.62
-12.46
-12.81
-2.09
-3.27
-1.61
-1.74
-0.1
-0.01
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-184.04
-249.51
-328.03
-318
7.13
-1.9
-2.57
-21.89
-29.75
-22.91
-24.87
-12.4
-2.98
-1.08
-1.08
-1.1
-1.11
Book Value per Share
307.18
251.43
104.59
67.78
36.32
30.55
29.32
18
3.67
3.39
-7.9
-3.59
-0.09
-0.05
-0.06
-0.08
-0.09
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
4
12
12
12
12
Basic Weighted Avg Shares
6
6
8
9
7
9
9
9
5
3
2
1
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-138.44
-126.51
-57.03
-27.33
-75.33
-23.38
-46.06
-28.2
-47.63
-73.62
-122.3
-182.39
-573.03
- -
- -
- -
- -
Operating Margin (%)
4
6
5
9
11
4
7
4
4
3
16
1
1
- -
- -
- -
- -
Depreciation Expense
-21
-13
-5
-11
-12
-3
-7
-7
-5
-5
-12
-5
6
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-362.34
-197.92
-63.08
-125.15
-170.76
-27.66
-79.6
-82.85
-114.1
-184.98
-596.21
-408.53
1,878.48
- -
- -
- -
- -
Profit Margin (%)
-13
- -
-3
-8
-9
-9
-4
-11
-11
-8
-3
-2
- -
-1
-1
-1
-1
Working Capital
2
2
- -
- -
5
5
3
4
4
3
4
2
- -
- -
- -
- -
- -
LT Debt
44
40
21
16
10
9
10
7
2
2
-8
-7
- -
-1
-1
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-40.04
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-55.84%
-0.8%
23.8%
Free Cash Flow
24.41%
-20.34%
-16.96%
Net Income, GAAP
-11.4%
-77.53%
33.33%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.01
2023
- -
- -
-0.01
- -
-0.02
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
DXI Capital Corp. (DXIEF) is a Canada-based capital shell company with no significant current operations that completed a reverse takeover transaction in July 2025, resulting in its name change to VVT Med Inc. and a strategic shift into the medical device sector focused on varicose vein treatments. Previously engaged in the exploration and production of oil and gas properties primarily in Canada and the United States, the company now supports the development, manufacturing, and commercialization of minimally invasive, non-thermal, non-tumescent solutions for varicose vein treatment through its acquisition of V.V.T. Med Ltd., an Israel-based entity offering products with competitive advantages including faster treatment times, reduced pain without anesthesia, and quicker recovery; these offerings target physicians and patients seeking alternatives to traditional methods. Founded in 1968 under the name Dejour Mines Limited and formerly known as DXI Energy Inc. before renaming to DXI Capital Corp. in September 2020, it is headquartered in Vancouver, Canada, with the reverse takeover also involving Exiteam Acquisition Corp. to facilitate public listing on the TSX Venture Exchange under the new ticker VM as of July 2025, accompanied by a 4:67 share consolidation, concurrent financings raising approximately C$4.7 million through subscription receipts and convertible debentures, and issuance of units with warrants.

Company News

APIChatGPT
  • Extraction Oil & Gas (OTCMKTS:XOGAQ) & DXI Capital (OTCMKTS:DXIEF) Financial Review

  • Financial Contrast: DXI Capital (OTCMKTS:DXIEF) & Evolution Petroleum (NYSE:EPM)